secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001437749-23-027971
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AcelRx shareholders approve 1.5M share increase to 2020 equity plan; elect three directors
--------------------------------------------------------------------------------

- Shareholders approved amendment to increase shares under the 2020 Equity Incentive Plan by 1,500,000 (for: 6,562,640; against: 486,414; abstain: 35,579).
- Three Class III directors elected: Marina Bozilenko (6,746,727 for), Howard B. Rosen (6,691,709 for), Mark Wan (6,724,271 for).
- Advisory vote on named executive officer compensation passed with 6,543,669 for, 510,636 against, 30,328 abstain.
- Proposal to ratify Withum as auditor withdrawn after Audit Committee dismissed Withum and engaged BPM LLP effective October 2, 2023.
- Total shares represented at meeting: 7,084,633 out of 16,340,118 entitled to vote (43.4% turnout).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774923027971/0001437749-23-027971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774923027971/acrx20231010_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-027971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer